The Asia Pacific healthcare market is estimated to capture 34.6 percent of the global healthcare market by 2015. Frost &...
New Delhi: Avesthagen entered into a license agreement with a leading specialty chemicals company for its 100 percent ve...
Mumbai: Sun Pharmaceutical Industries reported a growth of 62 percent in its net sales for the quarter ending June 30, 2...
New Delhi: The Indian government has cleared 12 foreign direct investment (FDI) proposals worth $58.13 million. However...
Bangalore: Kemwell Biopharma's oral solids manufacturing facility located in Bangalore, India, has successfully complete...
Singapore: Netherlands-based IMCD has acquired India's Indchem International. The business of Mumbai-based Indchem has a...
Mumbai: Caraco Pharma subsidiary, Caraco Acquisition, highlighted that its tender offer to acquire all of the outstandin...
Singapore: The fifth BioSpectrum Asia Pacific Awards 2013 were given away at a glittering ceremony at Hotel Fort Canning...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: The Foreign Investment Promotion Board (FIPB) has cleared seven out of the ten investment proposals in the ph...
Singapore: The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to t...
Bangalore: Following a change in rules for importing active substances into the European Union for medicinal products fo...
Singapore: UK-based biopharma company, Xenetic Biosciences, said in a statement that the recruitment process for the tri...
Everything does not seem to be well in the pharmaceutical industry of Asia's third largest economy - India. Although the...
Singapore: Jubilant Life Sciences has joined the list of leading Indian drug makers who have received a warning from the...
Bangalore: Eminent biotechnologists, agricultural scientists and heads of agribiotech industry came together on Saturday...
Life sciences industry in the Asia Pacific recorded the double digit growth of 16.6 percent, reaching $128.26 billion in...
Bangalore: A new drug to treat prostate cancer, which was developed by Bangalore-based Jubilant Biosys and US-based coll...
